Pharmacovigilance : notifications et étude du cas d’un effet indésirable grave médicamenteux
| dc.contributor.advisor | Y. Cherrah | |
| dc.contributor.author | Soukaina Bennis | |
| dc.date.accessioned | 2023-09-15T13:40:06Z | |
| dc.date.accessioned | 2026-01-22T13:32:57Z | |
| dc.date.available | 2023-09-15T13:40:06Z | |
| dc.date.issued | 2014 | |
| dc.description.collaborator | B. Meddah | |
| dc.description.collaborator | R. Souleimani Bencheikh | |
| dc.description.collaborator | M. Kababri | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/18920 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Pharmacologie | fr_FR |
| dc.subject | Pharmacovigilance | fr_FR |
| dc.subject | Notifications | fr_FR |
| dc.subject | Effets indésirables médicamenteux | fr_FR |
| dc.subject | Anticancéreux | fr_FR |
| dc.subject | Imputabilité | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Pédiatrie | |
| dc.title | Pharmacovigilance : notifications et étude du cas d’un effet indésirable grave médicamenteux | fr_FR |
Files
Original bundle
1 - 1 of 1